NeuroRegen scaffold with BMMCs or MSCs transplantation
CAS-XDA-SCI/IGDB
Phase 1 mab active
Quick answer
NeuroRegen scaffold with BMMCs or MSCs transplantation for Spinal Cord Injury is a Phase 1 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Spinal Cord Injury
- Phase
- Phase 1
- Modality
- mab
- Status
- active